itmn

InterMune Soaring 90% in Early Pre-Market on European Commit

agency, chmp, commission, committee, disease, drug, ema, esbriet, eu, european, fibrosis, human, idiopathic, intermune, ipf, itmn, lung, markets, medicinal, medicines, mild, products, pulmonary, treatment, use

InterMune (ITMN) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a marketing authorization for Esbriet (pi

By FNN Staff
root@fnn-online.com

Latest News from FNNO

Shares of Universal Health Services Have...

Shares of Universal Health Services (NYSE:UHS) traded today at $123.41, breaking its 52 ...

Shares of TTM Technologies Have Risen Ab...

TTM Technologies (NASDAQ:TTMI) traded at a new 52-week high today of $9.38. Approximat ...

Recent 52-Week High Exceeded in Shares o...

Shares of Tsakos Energy Navigation (NYSE:TNP) traded at a new 52-week high today of $9. ...

Shares of Techne Rise Above Previous 52-...

Techne (NASDAQ:TECH) traded today at a new 52-week high of $103.00. So far today appro ...

Stratasys: New 52-Week Low Set Today (SS...

Shares of Stratasys (NASDAQ:SSYS) traded at a new 52-week low today of $50.70. So far ...

The Inventure Group: New 52-Week Low Set...

The Inventure Group (NASDAQ:SNAK) traded today at a new 52-week low of $8.80. Approxim ...

Watch for Continued Gains in Shares of S...

Shares of Six Flags Entertainment (NYSE:SIX) traded today at $50.53, breaking its 52-we ...

Watch for Continued Gains in Shares of S...

Shares of SVB Financial (NASDAQ:SIVB) traded at a new 52-week high today of $135.00. T ...

Most Popular Video News